Registry of Lobbyists
| Organization: | Innovative Medicines Canada/Médicaments novateurs Canada |
| Associated registration: | 778662-371-26 |
| Communication date: | 2012-07-11 |
| Posted date: | 2012-10-10 |
| Designated Public Office Holders who participated in the communication: |
Gauri Screenivasan,
Parliamentary Affairs
House of Commons |
| Subject Matter of the communication: | Health, Industry, Intellectual Property, International Trade |
| Communication Report amended on: | 2012-10-10 previous entry: 371-232309 |
| Reason for amendment: | As per the letter received from the Office of the Commissioner of Lobbying of Canada (dated Oct. 9, 2012), where we were informed that Mr. Rob Gillezeau is not a designated public officer holder (DPOH). Therefore, this amendment is updating the report. |
| Responsible Officer who filed this communication report: | RUSSELL WILLIAMS |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |